Bone Marrow Plasma Cell Assessment before Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Lymphocyte subset analysis for the assessment of treatment-related complications after autologous stem cell transplantation in multiple myeloma

(2012) Sung-Eun Lee et al.   CYTOTHERAPY

Relevance and Clinical Implications of Tumor Cell Mobilization in the Autologous Transplant Setting

(2010) John F. DiPersio et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myeloma

(2010) Mervi Putkonen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation

(2009) Jin Seok Kim et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

(2008) B. Paiva et al.   BLOOD

Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma

(2008) H. G. Kopp et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

(2008) R A Kyle et al.   LEUKEMIA